Neurocrine Biosciences, Inc. revenue for the last year amounted to 2.36 B USD, the most of which — 2.36 B USD — came from its highest performing source at the moment, Pharmaceuticals, the year earlier bringing 1.89 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Neurocrine Biosciences, Inc. 2.36 B USD, and the year before that — 1.89 B USD.